The global collagen wound dressing market size is USD 6.4 billion in 2021 and is expected to reach a CAGR of 5.3% during the forecast period 2022-2028. Collagen is derived from animals, usually pigs, cattle, and horses. Collagen supports effectively development of cells at affected area. Collagen wound dressing very significant in patients with diabetes than the traditional wound dressing. These may be anti-microbial or non-antimicrobial. Global collagen wound dressing market is expected to grow at significant rates over the forecast period owing the growing number of skin and other injuries around the world. Market players are adopting strategies such as acquisitions and mergers to increase their market share globally. For instance, in July 2013, Concepts Inc. as acquired UK based global leader Systagenix, to strengthen its position in global advanced wound care market. Furthermore, companies also collaborating with the research organizations and institutes to advance the wound care treatments including the collagen wound dressing. For Instance, in June 2017, AMOEBA announced today the development of a collaboration with VISCUS BIOLOGICS in order to carry out collective testing on a new wound care application in the field of human health.
In December 2020, The GUIDOR® Synthetic Bone Graft and Membrane Business of Sunstar has been acquired by Collagen Matrix. Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical devices and a Linden Capital Partners portfolio company, announced today the acquisition of Sunstar’s Degradable Solutions division (the “Company”), which includes the GUIDOR® branded line of resorbable synthetic medical implants.
In 2019, Collagen Matrix, Inc. Spine business unit has received FDA 510(k) approval for their revolutionary line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix.